Page last updated: 2024-10-25

ciprofloxacin and Dengue

ciprofloxacin has been researched along with Dengue in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Scroggs, SLP1
Gass, JT1
Chinnasamy, R1
Widen, SG1
Azar, SR1
Rossi, SL1
Arterburn, JB1
Vasilakis, N1
Hanley, KA1

Other Studies

1 other study available for ciprofloxacin and Dengue

ArticleYear
Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness.
    Virology, 2021, 01-02, Volume: 552

    Topics: Adaptation, Biological; Animals; Antiviral Agents; Biological Evolution; Cell Line; Chlorocebus aeth

2021